Search

You searched for "RVO"

116 results found

Canon Medical announces Sense Medical as new UK distributor

25 January 2023 | Contracts & Distributors
Canon Medical Systems Europe today announced that it has signed an agreement with Sense Medical to be the official exclusive distributor of their ophthalmic eye care products within the United Kingdom and Ireland.

Trends in Ophthalmology Meeting 2023

2 March 2023 -3 March 2023
The chill of an early spring day was warmed by the buzz of excitement as nearly 150 attendees arrived in central London for the first face-to-face annual Trends in Ophthalmology meeting since the pandemic. Chaired by Ms Susie Morley, attendees...

Proning and the pandemic - ocular complications seen in critical care

6 April 2021 | | EYE - Vitreo-Retinal, EYE - Orbit, EYE - Cornea, EYE - General
Priyanka Sanghi and her co-authors explore the ocular complications seen in critical care units throughout the country as we treat patients through this challenging time. The SARS-Cov-2 (COVID-19) pandemic has placed the NHS and critical care services under immense strain,...

Glaucoma: 30 years on

30 November 2023
Back in 1993, the late and great Barry Cullen FRCS (Cavan born, Dublin trained), the first editor of Eye News, asked me to write an article about the current treatment of chronic open angle glaucoma (COAG). At the time I...

Restoring sight and embracing culture: A voluntary cataract surgery experience in Morocco

2 October 2025 | | EYE - Cataract
It all came from networking Doing volunteer work is an integral part of being a doctor. Helping and treating those in need without financial recognition embodies righteousness and a pure spirit. As healthcare providers, we have an unwritten duty to...

The Leicester Grading System for Foveal Hypoplasia

1 April 2020 | | EYE - Paediatrics, EYE - Neuro-ophthalmology, EYE - Orbit, EYE - General
The University of Leicester Ulverscroft Eye Unit have published the first medical grading system named after the city of Leicester. Infantile nystagmus is characterised by constant and involuntary eye movements and affects 24 per 10,000 people [1]. Onset is usually...

Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression and preserve RPE and photoreceptor integrity

5 June 2023 |
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterised by progressive, irreversible loss of the retinal pigment epithelium (RPE) and photoreceptors and is estimated to account for approximately 10% of AMD-related blindness [1-4]. The Age-Related Eye...

My top five: Uses of artificial intelligence in ophthalmology

3 August 2023 | | EYE - General
Artificial Intelligence (AI) has emerged as a prominent topic of discussion within the field of ophthalmology, captivating researchers and practitioners alike. Although recent attention has been drawn to the integration of AI in ophthalmology, it’s important to recognise that AI...

My Top Five: Uses of artificial intelligence in ophthalmology

3 August 2023 | | EYE - General
Artificial Intelligence (AI) has emerged as a prominent topic of discussion within the field of ophthalmology, captivating researchers and practitioners alike. Although recent attention has been drawn to the integration of AI in ophthalmology, it’s important to recognise that AI...

The ocular manifestations of COVID-19: an overview of current literature

6 April 2021 | | EYE - Cornea, EYE - Vitreo-Retinal, EYE - Neuro-ophthalmology
Although respiratory symptoms are the most frequent manifestation of COVID-19, multi-organ involvement has been demonstrated, including ocular manifestations. The author investigates how the eye can be affected. The SARS-CoV-2 virus responsible for the COVID-19 pandemic has presented a significant public...

IN FOCUS - The achievements and lasting effects of VISION 2020

1 April 2020 | | EYE - General
Blindness is a major public health problem globally. The first estimate of global blindness by the World Health Organization (WHO) in 1972 provided a figure of 10 to 15 million, which was considered an underestimate [1]. In 1999, an extraordinary...

Landmark review of glaucoma treatment and research published by Moorfields-led team

22 September 2023 | moorfields, glaucoma, research, developments, guzzard, the eagle, MIGS, Omni
Four world-leading experts, including Hari Jayaram and Gus Gazzard from Moorfields, have combined their knowledge with the findings from over 150 peer-reviewed study publications to produce a landmark paper published in the Lancet.